Skip to content

Startup & venture capital news

SpectaCell launches with EUR 6m seed funding

imec.xpand leads investment in cell-analysis technology

By /

LinkedInX
SpectaCell team seated in front of a patterned backdrop.
Source: EU-Startups.

SpectaCell publicly announced EUR 6 million in seed funding on Friday 9 October 2026, led by imec.xpand. The Belgian company combines research from imec, VIB and Ghent University in a platform that analyses how individual cells respond to treatments. Founded by Tony Montoye, Mathieu Rabaey, Veronique De Vroey and Jan Van de Velde, it is developing tools for drug development and manufacturing. SpectaCell says its imaging and data-analysis approach can provide clearer information about cell interactions. The financing supports platform development and commercialisation with pharmaceutical and biotechnology partners, bringing semiconductor expertise into the practical research requirements of advanced immune therapies.

Keep reading

More Funding

All stories